Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

More articles from Interstitial lung diseases

  • Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis
    Nasreen Khalil, Helene Manganas, Christopher J. Ryerson, Shane Shapera, Andre M. Cantin, Paul Hernandez, Eric E. Turcotte, Joseph M. Parker, John E. Moran, Gary R. Albert, Renata Sawtell, Aline Hagerimana, Pierre Laurin, Lyne Gagnon, Frank Cesari, Martin Kolb
    European Respiratory Journal Mar 2019, 53 (3) 1800663; DOI: 10.1183/13993003.00663-2018
  • A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis
    Pauline T. Lukey, Stephen A. Harrison, Shuying Yang, Yim Man, Beverley F. Holman, Alaleh Rashidnasab, Gabrielle Azzopardi, Michael Grayer, Juliet K. Simpson, Philippe Bareille, Lyn Paul, Hannah V. Woodcock, Richard Toshner, Peter Saunders, Philip L. Molyneaux, Kris Thielemans, Frederick J. Wilson, Paul F. Mercer, Rachel C. Chambers, Ashley M. Groves, William A. Fahy, Richard P. Marshall, Toby M. Maher
    European Respiratory Journal Mar 2019, 53 (3) 1801992; DOI: 10.1183/13993003.01992-2018
  • The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study
    Sebastiano Emanuele Torrisi, Brett Ley, Michael Kreuter, Marlies Wijsenbeek, Eric Vittinghoff, Harold R. Collard, Carlo Vancheri
    European Respiratory Journal Mar 2019, 53 (3) 1801587; DOI: 10.1183/13993003.01587-2018
  • Procedure volume and mortality after surgical lung biopsy in interstitial lung disease
    Jolene H. Fisher, Shane Shapera, Teresa To, Theodore K. Marras, Andrea Gershon, Sharon Dell
    European Respiratory Journal Feb 2019, 53 (2) 1801164; DOI: 10.1183/13993003.01164-2018
  • Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study
    Claire M. Nolan, Matthew Maddocks, Toby M. Maher, Winston Banya, Suhani Patel, Ruth E. Barker, Sarah E. Jones, Peter M. George, Paul Cullinan, William D-C. Man
    European Respiratory Journal Feb 2019, 53 (2) 1801186; DOI: 10.1183/13993003.01186-2018
  • Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes
    Raphael Borie, Diane Bouvry, Vincent Cottin, Clement Gauvain, Aurélie Cazes, Marie-Pierre Debray, Jacques Cadranel, Philippe Dieude, Tristan Degot, Stephane Dominique, Anne Sophie Gamez, Madeleine Jaillet, Pierre-Antoine Juge, Arturo Londono-Vallejo, Arnaud Mailleux, Hervé Mal, Catherine Boileau, Christelle Menard, Hilario Nunes, Gregoire Prevot, Sebastien Quetant, Patrick Revy, Julie Traclet, Lidwine Wemeau-Stervinou, Marie Wislez, Caroline Kannengiesser, Bruno Crestani
    European Respiratory Journal Feb 2019, 53 (2) 1800508; DOI: 10.1183/13993003.00508-2018
  • No relevant pharmacokinetic drug–drug interaction between nintedanib and pirfenidone
    Luca Richeldi, Sophie Fletcher, Huzaifa Adamali, Nazia Chaudhuri, Sabrina Wiebe, Sven Wind, Kathrin Hohl, Andrew Baker, Rozsa Schlenker-Herceg, Susanne Stowasser, Toby M. Maher
    European Respiratory Journal Jan 2019, 53 (1) 1801060; DOI: 10.1183/13993003.01060-2018
  • Predicting outcomes in rheumatoid arthritis related interstitial lung disease
    Joseph Jacob, Nikhil Hirani, Coline H.M. van Moorsel, Srinivasan Rajagopalan, John T. Murchison, Hendrik W. van Es, Brian J. Bartholmai, Frouke T. van Beek, Marjolijn H.L. Struik, Gareth A. Stewart, Maria Kokosi, Ryoko Egashira, Anne Laure Brun, Gary Cross, Joseph Barnett, Anand Devaraj, George Margaritopoulos, Ronald Karwoski, Elisabetta Renzoni, Toby M. Maher, Athol U. Wells
    European Respiratory Journal Jan 2019, 53 (1) 1800869; DOI: 10.1183/13993003.00869-2018
  • SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)
    Ganesh Raghu, Luca Richeldi, Bruno Crestani, Peter Wung, Raphael Bejuit, Corinne Esperet, Christian Antoni, Christina Soubrane
    European Respiratory Journal Dec 2018, 52 (6) 1801130; DOI: 10.1183/13993003.01130-2018
  • Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study
    Sabrina Bajwah, Joanna M. Davies, Hanan Tanash, David C. Currow, Adejoke O. Oluyase, Magnus Ekström
    European Respiratory Journal Dec 2018, 52 (6) 1801278; DOI: 10.1183/13993003.01278-2018

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society